TAK, US8740602052

Takeda announces second-quarter call as Takeda stock costs EUR 17.50

Published on 10/16/2026 at 09:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Takeda sets its second-quarter call for October 29, 2026. Takeda stock costs EUR 17.50 on October 16, 2026 in Berlin.

Results calendar and operating trends

Takeda announced its second-quarter results call on October 15, 2026.
Core revenue fell 0.5 percent to JPY 1.22 trillion in the first quarter of fiscal 2026.
Takeda stock trades at EUR 17.50 at 9:08 a.m. CEST at Lang & Schwarz on October 16, 2026.
Takeda's market capitalization stood at USD 61.5 billion as of October 15, 2026.

TAK, US8740602052, Illustration mit AI erstellt.

Takeda Pharmaceutical Company Limited (US8740602052) was trading at EUR 17.50 at Lang & Schwarz at 9:08 a.m. CEST on October 16, 2026. The company announced on October 15 that it will present second-quarter fiscal 2026 results on October 29, according to Takeda.

October call sets the next test

The October 29 event will include management's presentation and a question-and-answer session. Takeda will publish its presentation materials at 2:30 a.m. EDT on the same date, according to the company release.

The timing gives investors a clear checkpoint for the company's fiscal 2026 outlook. Takeda's investor page identifies the event as the earnings announcement for the second quarter of fiscal 2026 and lists the Tokyo Stock Exchange and NYSE as trading venues.

What did the first quarter show?

Takeda's first-quarter fiscal 2026 core revenue declined 0.5 percent at constant exchange rates to JPY 1.22 trillion, while core operating profit fell 0.5 percent on the same basis, ScanX reported on September 17, 2026.

The underlying result contrasted with reported revenue growth of 10.2 percent, which the same report attributed to favorable currency movements. New launches grew 22.6 percent at constant exchange rates and represented 4 percent of revenue, providing a quantified measure of the pipeline contribution.

Dates investors can track

Takeda's next two substantiated dates are October 23, 2026, when oncology data are scheduled for presentation at the European Society for Medical Oncology Congress, and October 29, 2026, for the second-quarter results call. The oncology timetable was reported by Simply Wall St, while the earnings date comes from Takeda.

The stock's market setting

Takeda's market capitalization was USD 61.5 billion as of October 15, 2026. Its primary US listing showed a 52-week range of USD 12.99 to USD 19.89, with the latest quoted USD price at USD 19.45 after the US session on October 15, 2026.

The combination of a 0.5 percent constant-currency revenue decline and double-digit reported growth makes the October results especially important for separating operating performance from currency effects.